Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Clinical drug testing at the point of care.2nd edition. AACC Press, Washington (DC)2004
- National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.Clin Chem. 2003; 49: 357-379
- Urine drug testing in pain medicine.J Pain Symptom Manage. 2004; 27: 260-267
- Opioid guidelines in the management of chronic non-cancer pain.Pain Physician. 2006; 9: 1-39
- Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay.Am J Clin Pathol. 2008; 129: 796-801
- Use of on-site testing for drugs of abuse.Clin Chem. 2002; 48: 1639-1646
- Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium.Clin Chim Acta. 2001; 303: 1-17
- Drugs and ethanol.National Academy of Clinical Biochemistry, Washington (DC)2006
- Comparison of eight commercial on-site screening devices for drugs-of-abuse testing.Scand J Clin Lab Invest. 2001; 61: 325-331
- Current developments in drug testing in oral fluid.Ther Drug Monit. 2008; 30: 196-202
- Monitoring ethanol exposure in a clinical setting by analysis of blood, breath, saliva, and urine.Alcohol Clin Exp Res. 1999; 23: 1446-1451
- Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.J Anal Toxicol. 2006; 30: 106-111
- Comparison of three commercial tests for buprenorphine screening in urine.Ann Clin Biochem. 2007; 44: 563-565
- Signify ER Drug Screen Test evaluation: comparison to Triage Drug of Abuse Panel plus tricyclic antidepressants.Clin Chim Acta. 2003; 328: 31-38
- Determination of tricyclic antidepressants for ED analysis.Am J Emerg Med. 1994; 12: 513-516
- Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT).Clin Chim Acta. 2001; 307: 27-32
- Clinical evaluation of the Triage analytic device for drugs-of-abuse testing.Clin Chem. 1996; 42: 1433-1438
- Point-of-care testing for drugs of abuse in an urban emergency department.Ann Clin Lab Sci. 2002; 32: 383-386
- Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.J Anal Toxicol. 2004; 28: 485-488
- Evaluation of the DrugCheck 9 on-site immunoassay test cup according to a standard method validation protocol.J Anal Toxicol. 2004; 28: 190-197
- A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.J Anal Toxicol. 2006; 30: 50-56
- Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.J Emerg Med. 2005; 28: 389-394
- Evaluation of the triage system for emergency drugs-of-abuse testing in urine.J Anal Toxicol. 1993; 17: 241-245
- Accuracy of five on-site immunoassay drugs-of-abuse testing devices.J Anal Toxicol. 1999; 23: 119-124
Article info
Identification
Copyright
© 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
